Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.82 |
| ▸ | NT5E | P21589 | 1/20 | 0.77 |
| ▸ | KRAS | P01116 | 5/20 | 0.74 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.73 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.69 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.69 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.69 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.69 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.67 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.67 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.67 |
| ▸ | IMPDH2 | P12268 | 5/20 | 0.66 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.66 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.66 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.66 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.66 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13210265 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| SCHEMBL18775378 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| SCHEMBL101367 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| SCHEMBL37405 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| SCHEMBL17072523 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| SCHEMBL23969756 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| SCHEMBL80058 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| Triphosphate SCHEMBL28597197 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| Ammonia Solution, Strong SCHEMBL22134209 | 0.99 | TGM2 (0.81) | TGM2NT5EKRASFUT5P2RX3 | |
| Ammonia Solution, Strong SCHEMBL22134210 | 0.99 | TGM2 (0.81) | TGM2NT5EKRASFUT5P2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11376272-B2 | Methods of modulating immune activity | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2022-07-05 | — | — | US | disclosed |
| US-20210299155-A1 | METHODS OF MODULATING IMMUNE ACTIVITY | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-30 | — | — | US | disclosed |
| US-20170112948-A1 | Inorganic-organic hybrid compound | Karlsruher Institut für Technologie (DE) | 2017-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11376272-B2 | Methods of modulating immune activity | STING1, IRF3, CGAS | TGM2 3205/4885NT5E 84/4885KRAS 2148/4885 |
| US-20170112948-A1 | Inorganic-organic hybrid compound | SLCO4C1, SLCO2A1, SLCO1A2 | TGM2 3027/4885NT5E 2746/4885KRAS 3753/4885 |
| US-20210299155-A1 | METHODS OF MODULATING IMMUNE ACTIVITY | STING1, IRF3, CGAS | TGM2 3383/4885NT5E 58/4885KRAS 2487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.